Lidonel 35 mg (Risedronate Sodium Hydrate)

Adult dose

1. Adults : Administer 35 mg of risedronate sodium orally once weekly. 2. Elderly patients : No dosage adjustment is necessary in elderly patients (over 60 years of age), as the bioavailability and pharmacodynamics of this drug are similar to those in younger people. 4. Patients with renal impairment : No dosage adjustment is necessary in patients with a creatinine clearance of 30 mL/min or greater. This drug is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30 mL/min. ○ Food interferes with the absorption of this drug. For adequate absorption, take it at least 30 minutes before breakfast, or at least 2 hours before or after food or beverages at any time of day. To facilitate passage of this drug into the stomach and reduce the possibility of esophageal irritation, take it while sitting or standing upright with a sufficient amount of plain water (170 ∼ 230 mL). Taking it with other beverages, including mineral water, may decrease absorption. Do not chew or suck this drug because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. ○ If a patient forgets to take a dose on the scheduled day, take it the next morning when remembered. Resume the next dose on the originally scheduled day. Do not take 2 tablets on the same day.

Child dose

Safety and efficacy in children under 18 years of age have not been established.

This medication may irritate the stomach and esophagus, so special caution is needed for individuals with esophageal disorders or conditions such as gastritis or ulcers. After taking the medication, do not lie down immediately, and take it with a sufficient amount of water. Additionally, do not lie down for at least 30 minutes after taking it. This medication should not be used in patients with certain esophageal disorders, hypocalcemia, pregnant or nursing women, or those with severe kidney dysfunction. Moreover, individuals with lactose intolerance should not take this medication. During treatment, avoid taking medications or foods containing divalent cations such as calcium, magnesium, or iron, and keep to the prescribed intervals for taking this medication. Rarely, prolonged use of this medication may lead to serious side effects such as osteonecrosis of the jaw or atypical fractures; if any unusual symptoms occur, consult a doctor immediately. Prior to use, any metabolic bone and mineral disorders such as hypocalcemia or vitamin D deficiency must be treated, and sufficient intake of calcium and vitamin D is important. Avoid use during pregnancy or breastfeeding and consult a healthcare professional immediately if side effects occur. The safety of this medication in children under 18 has not been established, and elderly patients may use it without special caution. In case of overdose, calcium and phosphate levels in the blood may decrease; notify a healthcare professional immediately and receive appropriate treatment. Store this medication out of reach of children and do not transfer it to another container.

• esophagitis
• esophageal ulcer
• esophageal erosion
• esophageal obstruction
• esophageal perforation
• hemorrhage
• infection
• back pain
• accidental injury
• pain

This medication should be stored in a tightly sealed container to prevent air exposure. The storage temperature should be maintained between 1 degree and 30 degrees Celsius. This helps maintain the effectiveness of the medication and prevents degradation.

Appearance

Pale orange rectangular film-coated tablet

Package unit

4 tablets/box [4 tablets/PTP×1]